GLP-1 Archives

Ketamine Patients and GLP-1 Patients Are Often the Same People

47 percent of peptide clinics now offer a GLP-1. Depression, drinking and metabolic disease cluster in the same patients.

The VA Is Testing a GLP-1 for Alcohol Use Disorder

The Department of Veterans Affairs began recruiting on July 28. The study tests semaglutide as a treatment for alcohol use disorder. More than 600 veterans will take part across 18 medical centers. For clinics running mental health and weight loss programs together, this study sits on the seam between them. Running two service lines under […]

Five Months After Lilly’s B12 Warning, 1 in 7 Tirzepatide Clinics Still Advertises the Combination

Eli Lilly warned in March that compounded tirzepatide with B12 forms an uncharacterized impurity. We checked 800 clinic websites to see how many still advertise the combination.

The Anatomy of an FDA GLP-1 Warning Letter

The FDA's GLP-1 crackdown targets your website, not your medicine. Here is the exact language that draws warning letters, and what to say instead.

GLP-1s Got You Here — Now What? The Next Frontier of Peptide Wellness

Ozempic opened the door. For patients ready to go further, the broader world of peptide therapy offers tools for cognition, healing, longevity, and mental health.

What Are Peptides, and Why Is Everyone in the Wellness World Talking About Them?

Peptides have powered the GLP-1 revolution. Now the broader category is stepping into the spotlight — and patients are paying attention.